Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Claude Barbare

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Letters|January 2, 2014
New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinomaAntoine Galmiche, Bruno Chauffert, Jean-Claude Barbare
Seminars in Oncology|April 24, 2007
Hepatocellular carcinoma (HCC): an updatePhilippe Rougier, Emmanuel Mitry, Jean-Claude Barbare, et al.
Bulletin Du Cancer|July 29, 2017
[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017]Charlotte Costentin, Nathalie Ganne-Carrié, Benoit Rousseau, et al.
Journal of Hepatology|October 25, 2016
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western countryNathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
The Oncologist|December 28, 2014
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinomaMomar Diouf, Franck Bonnetain, Jean-Claude Barbare, et al.
International Journal of Cancer|March 19, 2013
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenibChristophe Louandre, Zakaria Ezzoukhry, Corinne Godin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2016
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinomaChloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, et al.
European Journal of Gastroenterology & Hepatology|May 30, 2009
Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosisVincent Jouannaud, Jean-François Cadranel, Patrice Dumouchel, et al.
Digestive Diseases and Sciences|July 27, 2019
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis CCharlotte E Costentin, Philippe Sogni, Bruno Falissard, et al.
Gastroenterologie Clinique Et Biologique|March 7, 2006
[Acute colitis closely following the beginning of celecoxib treatment]Zaher Houmani, Audrey Imbert, Jean-Christophe Duchmann, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Letters|January 2, 2014
New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinomaAntoine Galmiche, Bruno Chauffert, Jean-Claude Barbare
Seminars in Oncology|April 24, 2007
Hepatocellular carcinoma (HCC): an updatePhilippe Rougier, Emmanuel Mitry, Jean-Claude Barbare, et al.
Bulletin Du Cancer|July 29, 2017
[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017]Charlotte Costentin, Nathalie Ganne-Carrié, Benoit Rousseau, et al.
Journal of Hepatology|October 25, 2016
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western countryNathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
The Oncologist|December 28, 2014
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinomaMomar Diouf, Franck Bonnetain, Jean-Claude Barbare, et al.
International Journal of Cancer|March 19, 2013
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenibChristophe Louandre, Zakaria Ezzoukhry, Corinne Godin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2016
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinomaChloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, et al.
European Journal of Gastroenterology & Hepatology|May 30, 2009
Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosisVincent Jouannaud, Jean-François Cadranel, Patrice Dumouchel, et al.
Digestive Diseases and Sciences|July 27, 2019
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis CCharlotte E Costentin, Philippe Sogni, Bruno Falissard, et al.
Gastroenterologie Clinique Et Biologique|March 7, 2006
[Acute colitis closely following the beginning of celecoxib treatment]Zaher Houmani, Audrey Imbert, Jean-Christophe Duchmann, et al.
Pageof 4